-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HzRws8BxZORN4jjqOWQzbhd6MmGx5vBXD1lH77Q06kfe+9Y61KP52TKB2+AYeNyx S64REjqRIwe0trPSji79yQ== 0001299933-06-006895.txt : 20061026 0001299933-06-006895.hdr.sgml : 20061026 20061026151817 ACCESSION NUMBER: 0001299933-06-006895 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061025 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20061026 DATE AS OF CHANGE: 20061026 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ROCHESTER MEDICAL CORPORATION CENTRAL INDEX KEY: 0000868368 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411613227 STATE OF INCORPORATION: MN FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-18933 FILM NUMBER: 061165655 BUSINESS ADDRESS: STREET 1: ONE ROCHESTER MEDICAL DR CITY: STEWARTVILLE STATE: MN ZIP: 55976 BUSINESS PHONE: 5075339600 MAIL ADDRESS: STREET 1: ONE ROCHESTER MEDICAL DR CITY: STEWARTVILLE STATE: MN ZIP: 55976 8-K 1 htm_15824.htm LIVE FILING Rochester Medical Corporation (Form: 8-K)  

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   October 25, 2006

Rochester Medical Corporation
__________________________________________
(Exact name of registrant as specified in its charter)

     
Minnesota 0-18933 41-1613227
_____________________
(State or other jurisdiction 		_____________
(Commission 		______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
One Rochester Medical Drive, Stewartville, Minnesota   55976
_________________________________
(Address of principal executive offices) 		  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   507-533-9600

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 1.01 Entry into a Material Definitive Agreement.

On October 25, 2006, the Compensation Committee of the Board of Directors of Rochester Medical Corporation (the "Company") amended the Company’s cash bonus management incentive plan for the fiscal year ending September 30, 2006 (the "Plan"), with respect to the bonus criteria used for Philip J. Conway, Vice President, Production Technologies. Because of the shift in corporate-wide goals during the 2006 fiscal year as a result of the acquisition of certain assets of Coloplast A/S and Mentor Medical Limited, and the related establishment of the Company’s operations in the United Kingdom through its newly formed subsidiary, Rochester Medical Limited, the Compensation Committee concluded that basing Mr. Conway’s bonus on measurable production goals related to productivity, scrap reduction and intermittent cost reduction did not adequately reflect Mr. Conway’s responsibilities or contributions to the Company during the fiscal year. Rather, Mr. Conway will be entitled to earn bonus i ncentive compensation under the Plan on a basis similar to the rest of the Company’s management personnel based upon the Company’s financial performance, with 50% of the weighted performance criteria based on the Company’s net sales and 50% based on the Company’s operating income.





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Rochester Medical Corporation
          
October 26, 2006   By:   /s/ David A. Jonas
       
        Name: David A. Jonas
        Title: Chief Financial Officer
-----END PRIVACY-ENHANCED MESSAGE-----